Market News & Trends
BioXcel Strengthens Position in Immuno-Oncology With Dedicated Big Data Analytics Platform
BioXcel Corporation recently announced the launch of its first in class PharmGPS Oncology and Immuno-Oncology Suite. The platform’s comprehensive big data approach provides industry stakeholders…
Case Study of Formulating “One & Done” Daily Dosing Involving a Highly Water-Soluble API
By: Michael DeHart, PhD The Issue Metrics Contract Services was approached by a client with a commercialized drug product indicated…
Geron Announces Initiation of Janssen Phase II/III Clinical Trial
Geron Corporation recently announced the dosing of the first patient in a Phase II/III clinical trial to evaluate imetelstat in patients with myelodysplastic syndromes (MDS).…
DelMar Pharmaceuticals to Collaborate With MD Anderson Cancer Center
DelMar Pharmaceuticals, Inc. recently announced it has entered into a collaboration with the University of Texas MD Anderson Cancer Center (MD Anderson) to accelerate the…
Catalent Biologics Announces Collaboration With Roche on SMARTag Technology
Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, recently announced, through its wholly…
Sucampo Enters Exclusive Option & Collaboration Agreement With Cancer Prevention Pharmaceuticals
Sucampo Pharmaceuticals, Inc. recently announced an option and collaboration agreement under which Cancer Prevention Pharmaceuticals, Inc. (CPP) has granted Sucampo the sole option to acquire…
ProImmune Introduces ProT2 MHC Class II Tetramer Reagents to Study Antigen-Specific CD4+ T Cell Immune Responses
ProImmune recently announced the introduction of ProT2, a range of Human MHC Class II tetramer reagents for tetramer analyses in the study of antigen-specific CD4+…
California Institute for Biomedical Research Enters Worldwide Strategic Collaboration With Pfizer
The California Institute for Biomedical Research (Calibr), a non-profit translational research institute, recently announced it has entered into a global strategic collaboration with Pfizer Inc.…
Chronic Obstructive Pulmonary Disease Treatment Pipeline Lacks Robust Innovation
Despite an influx of new therapies over recent years, the Chronic Obstructive Pulmonary Disease (COPD) treatment market has a number of unmet needs, and the…
Glioblastoma Treatment Market Will Expand Five-Fold to $3.3 Billion
The glioblastoma treatment market will increase fivefold from $659 million in 2014 to $3.3 billion by 2024, representing a rapid Compound Annual Growth Rate (CAGR)…
Scholar Rock Announces $36-Million Financing
Scholar Rock recently announced a $36-million Series B financing. Fidelity Management and Research Company led the financing with participation from additional new investor Cormorant Asset…
Genomics & Vertex Collaborate to Identify Target Therapeutic Pathways
Genomics plc recently announced that Vertex Pharmaceuticals will use Genomics’ integrated database and state-of-the-art analysis tools to inform its drug research and development. These tools…
Merus & Gustave Roussy Form Strategic Collaboration to Develop Innovative Bispecific Antibodies
Merus B.V. and Institut Gustave Roussy recently announced entry into a strategic collaboration to jointly develop bispecific antibodies for therapeutic immuno-oncology applications. Under the terms…
Lion Biotechnologies Submits INDA to Conduct Cancer Studies
Lion Biotechnologies, Inc. recently announced it has filed an INDA with the US FDA to conduct clinical trials of LN-145 in the treatment of cervical…
Fibrocell & Intrexon Announce Exclusive Channel Collaboration
Fibrocell Science, Inc. and Intrexon Corporation recently announced an Exclusive Channel Collaboration (ECC) for the development of genetically modified fibroblasts to treat chronic inflammatory and…
Cytokinetics Announces Start of Phase II Clinical Trial
Cytokinetics, Inc. recently announced that its first Phase II clinical trial of CK-2127107, a novel fast skeletal muscle troponin activator, in patients with spinal muscular…
Unilife Surges on Wearable Injector Devices Pact With Amgen
Unilife Corporation stock jumped more than 100% this morning after the company announced a new deal with Amgen to develop wearable injector devices. Pennsylvania-based Unilife…
US Demand for Drug Delivery Products to Reach $251 Billion
US Demand for Drug Delivery Products to Reach $251 Billion Demand for drug delivery products in the US is projected to increase 6.1%…
Haselmeier Self-Injection Devices Go Connected
Haselmeier has added connectivity to its devices portfolio with the announcement of its new Axis-D-Connect Disposable Pen Injector. Haselmeier has partnered with the Austrian Institute…
Nanosphere Announces $10-Million Registered Public Offering
Nanosphere, Inc. recently announced the pricing of a public offering of the company’s common stock with expected total gross proceeds of approximately $10 million. The…
